Common Contracts
16 similar Warrant Agreement contracts by Orgenesis Inc., Ardelyx, Inc., Value Exchange International, Inc.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • August 26th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to Jacob Safier, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Amended and Restated Promissory Note, dated as of August __, 2024, among Orgenesis Maryland, LLC, Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Promissory Note”) and is subject to the terms and conditions of the Promissory Note.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • June 6th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to _____________ , or his registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain XXX Agreement dated as of XXX __, 2024, between Orgenesis Inc., a Nevada corporation (the “Company”), and the XXX owning the Purchaser (the “Advisor Agreement”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • March 7th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to XXXX, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 3, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • March 7th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to XXXX, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 3, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • January 5th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Loan Extension Agreement, dated as of January 1, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Loan Extension Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • January 5th, 2024 • Orgenesis Inc. • Pharmaceutical preparations
This Warrant is issued to Aharon Lukach, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Loan Extension Agreement, dated as of January 1, 2024, among Orgenesis Inc., a Nevada corporation (the “Company”), and the Purchaser (the “Loan Extension Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF VALUE EXCHANGE INTERNATIONAL, INC.Warrant Agreement • February 2nd, 2023 • Value Exchange International, Inc. • Services-miscellaneous business services
This Warrant is issued to ________________________________, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Credit Agreement, dated as of January 27, 2023, among Value Exchange International, Inc., a Nevada corporation (the “Company”), the Purchaser and certain other party thereto (the “Convertible Credit Agreement”) and is subject to the terms and conditions of the Convertible Credit Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to Yehuda Nir, or its registered assigns (including any successors or assigns, the “Lender”), pursuant to that certain Extension to the Convertible Loan Agreement, dated as of October 23, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Lender thereunder (the “Extenstion”) and is subject to the terms and conditions of the Extenstion.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • October 27th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to Ricky Neumann, or its registered assigns (including any successors or assigns, the “Lender”), pursuant to that certain Convertible Loan Extension Agreement, dated as of October 23, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Lender thereunder (the “Extenstion”) and is subject to the terms and conditions of the Extenstion.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • May 23rd, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to Ricky Neumann, or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of May 19, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • May 17th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of May 17, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • April 25th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Convertible Loan Agreement, dated as of April 21, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Convertible Loan Agreement”) and is subject to the terms and conditions of the Convertibe Loan Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • April 5th, 2022 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of March 30, 2022, among Orgenesis Inc., a Nevada corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORGENESIS INC.Warrant Agreement • January 22nd, 2020 • Orgenesis Inc. • Pharmaceutical preparations • Maryland
This Warrant is issued to [________], or its registered assigns (including any successors or assigns, the "Purchaser"), pursuant to that certain Securities Purchase Agreement, dated as of January 20, 2020, among Orgenesis Inc., a Nevada corporation (the "Company"), the Purchaser and certain other purchasers thereunder (the "Purchase Agreement") and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ARDELYX, INC.Warrant Agreement • July 13th, 2015 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Warrant is issued to , or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of June 2, 2015, among Ardelyx, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ARDELYX, INC.Warrant Agreement • July 13th, 2015 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Warrant is issued to , or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of June 2, 2015, among Ardelyx, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.
